New Delhi: The Health Ministry on Thursday said it has proposed an amendment to the New Drugs and Clinical Trials Rules, 2019, to bring antimicrobials. The proposed amendment has been initiated in view of concerns regarding the grant of manufacturing licences for antimicrobial products without adequate regulatory scrutiny, including the requirement for studies such as bioavailability/bioequivalence and stability studies.